AbbVie Inc. (ABBV) Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI Subcutaneous Induction in Patients with Crohn’s Disease

9 3 月, 2026

One Min Read

15 Views

原文: https://finance.yahoo.com/news/abbvie-inc-abbv-announces-positive-084634735.html

Last Update: 9 3 月, 2026

Written By

Other Articles

Previous

<div>Iran’s strategic oil island thrust into the spotlight as Middle East conflict escalates</div>

Next

【企業盈警】順客隆(00974)料全年虧損收窄至最多1800萬元人民幣

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept